Switch to Accessibility Site
Skip Content
Home » Physician Assistants »Kristin Ruiz, PA

Kristin Ruiz, PA

Kristin Ruiz, PA

Kristin Ruiz is a dedicated and experienced Physician Assistant at True North Neurology. Prior to becoming a Physician Assistant, Kristin worked at our practice as a Medical Assistant / Scribe where she was inspired to continue her education and career in neurology.

As part of her formal education and training, she earned her Master of Science in Physician Assistant Studies Degree at South University at Tampa with High Honors, as well as earning a Master of Arts in Medical Humanities, Compassionate Care and Bioethics Degree at Stony Brook University in New York. Prior to earning her master’s degrees, she earned her Bachelor of Science Degree in Biology at Siena College in New York.

Her interests include headaches, ADHD, sleep medicine, Botox procedures, trigger point injections, dementia, and memory impairment.

Kristin is also part of the True North Neurology Research Team as a Sub Investigator in several trials including:

Research Trials

  • Lundbeck 19356A: Interventional, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of IV eptinezumab in adolescents (12-17 years) for the preventive treatment of chronic migraine.
  • Lundbeck 19357A: Interventional, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of intravenous (IV) eptinezumab in pediatric patients (6 to 17 years) for the preventive treatment of episodic migraine.
  • Lundbeck 19379A: Long-term, open-label (dose-blinded), extension study of eptinezumab in children and adolescents with chronic or episodic migraine.
  • Suven CTP3S1502HT6: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Masupirdine (SUVN-502) for the Treatment of Agitation in Participants with Dementia of the Alzheimer’s Type.
  • Novartis Pharmaceuticals CLOU064C12302: A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib.

With her caring and calm personality, Kristin makes it a priority to listen to her patients while creating an environment for them to easily communicate their needs. She feels it is important to educate and empower her patients to really understand their condition and treatment plan which in turn helps make a more meaningful change in their lives.